Table 9.
Patient sampling schedule (h) | Measured [MX] (ng/ml) | E (ng/ml)a | %REb | |
---|---|---|---|---|
First analysis | Re-analysis after 9 months | |||
Pre-dose | no peak | no peak | not applicable | not applicable |
0.250 | 5.36 | 5.69 | 0.33 | 6.2 |
0.500 | 8.95 | 10.2 | 1.25 | 14.0 |
0.750 | 16.2 | 18.2 | 2.0 | 12.3 |
0.983 | 20.5 | 22.1 | 1.6 | 7.8 |
1.17 | 25 | 27.1 | 2.1 | 8.4 |
2.00 | 24.2 | 24.3 | 0.1 | 0.4 |
4.00 | 18.3 | 20 | 1.7 | 9.3 |
6.00 | 19 | 19.5 | 0.5 | 2.6 |
8.00 | 18.9 | 17.5 | −1.4 | −7.4 |
12.0 | 15.6 | 16.2 | 0.6 | 3.8 |
24.0 | 13.3 | 13.2 | −0.1 | −0.8 |
48.0 | 9.46 | 10 | 0.54 | 5.7 |
72.0 | 6.56 | 6.46 | −0.10 | −1.5 |
96.0 | 4.46 | 4.76 | 0.3 | 6.7 |
120 | 3.55 | 3.69 | 0.14 | 3.9 |
168 | 2.11 | 2.29 | 0.18 | 8.5 |
192 | 1.55 | 1.76 | 0.21 | 13.5 |
216 | 1.22 | 1.39 | 0.17 | 13.9 |
E (error) = value of first analysis − value of re-analysis
%RE (percent relative error) = (error/value of first analysis) × 100%